Celgene's most recent trend suggests a bearish bias. One trading opportunity on Celgene is a Bear Call Spread using a strike $145.00 short call and a strike $155.00 long call offers a potential 14.42% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $145.00 by expiration. The full premium credit of $1.26 would be kept by the premium seller. The risk of $8.74 would be incurred if the stock rose above the $155.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Celgene is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Celgene is bearish.
The RSI indicator is at 35.19 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Top Stock Reports for IBM, Celgene and Procter & Gamble
Wed, 18 Oct 2017 19:13:07 +0000
Top Stock Reports for IBM, Celgene and Procter & Gamble
Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals
Wed, 18 Oct 2017 13:55:01 +0000
Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals
Biogen Could Rise 20% on Healthy Outlook
Wed, 18 Oct 2017 10:00:00 +0000
Biogen shares were buoyed by strong revenue and earnings forecasts.
Celgene Blood Cancer Treatment: Just The Tip Of Its Disruptive Science?
Tue, 17 Oct 2017 20:47:14 +0000
Celgene became a biotech juggernaut thanks to a treatment for tricky blood cancers. Now drugs battling lupus, MS and more are on the stock’s potential hit list.
Top 3 Healthcare Stocks for 2017
Tue, 17 Oct 2017 20:25:00 +0000
These three healthcare stocks have been strong in 2017, and the upward trend may continue for the rest of the year.
Related Posts
Also on Market Tamer…
Follow Us on Facebook